SecBot SecBot
PRESS-RELEASE ·Filed Mar 20, 2026

CV

CapsoVision
MIXED
Impact 6/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

The $14 million raise improves liquidity but is dilutive; traders should monitor the upcoming full earnings release on March 26 for GAAP details and cash burn rate. Revenue growth should be assessed against cash usage and path to profitability.

DirectionMixed
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CV ▲ +4.66% at T+60d
NEUTRAL call +4.66% · α vs SPY -9.76% · entry $6.87 → $7.19
Entry = T+0 close
Mar 20, 2026
via day close
T+1d
+19.07%
call +19.07% · α +17.97%
$8.18
settled 7mo ago
T+5d
+9.32%
call +9.32% · α +11.47%
$7.51
settled 7mo ago
T+20d
-12.52%
call -12.52% · α -21.84%
$6.01
settled 6mo ago
T+60d
+4.66%
call +4.66% · α -9.76%
$7.19
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

CapsoVision announced preliminary, unaudited revenue of $3.9 million for Q4 2025 and $13.6 million for the full year 2025, alongside the closing of a $14 million private placement at $4.883 per share. The company also disclosed approximately $10.1 million in cash and investments as of December 31, 2025.

Key Financial Metrics

Revenue
$13.6M
Deal Value
$14.0M

Key Facts

  • Preliminary Q4 2025 revenue was $3.9 million
  • Full year 2025 revenue was $13.6 million
  • Closed $14 million private placement by issuing 2,867,089 shares at $4.883 per share
  • Cash, cash equivalents, restricted cash, and investments totaled $10.1 million as of December 31, 2025
  • Proceeds from financing will be used for R&D, sales and marketing, and general corporate purposes

Financial Impact

$14 million gross proceeds from dilutive financing; full-year revenue up from prior year but cash balance remains low at $10.1M

revenuecashdilution

Risk Factors

  • Dilution from issuance of nearly 2.87 million new shares
  • Preliminary financials lack detail on profitability, margins, or cash flow trends
  • Low cash balance pre-financing suggests ongoing reliance on capital markets

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3259701
16 reports for CV
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 4 of 8 best @ T+20▲ +10.53%Jul 7, 2026
Filters
Rows
Reports for CV — sortable, filterable
TypeNow
Sep 28, 2026
28d ago
8-K
BULLISH ★ 6/10
$6.92awaiting T+60—$6.89 (−0.43%)
Sep 28, 2026
28d ago
Press Release
BULLISH ★ 5/10
$6.92awaiting T+60—$6.89 (−0.43%)
Sep 23, 2026
4w ago
Insider Cluster
NEUTRAL ★ 4/10
$6.17awaiting T+60—$6.89 (+11.67%)
Sep 22, 2026
4w ago
Institutional Cluster
NEUTRAL ★ 3/10
$6.30awaiting T+60—$6.89 (+9.37%)
Sep 18, 2026
5w ago
424B5
BEARISH ★ 6/10
$6.70awaiting T+60—$6.89 (−2.84%)
Aug 24, 2026
9w ago
EFFECT
BEARISH ★ 7/10
$5.83awaiting T+60—$6.89 (−18.18%)
Aug 13, 2026
10w ago
S-3
BEARISH ★ 6/10
$6.46awaiting T+60—$6.89 (−6.66%)
Jul 21, 2026
13w ago
Insider Buy
BULLISH ★ 5/10
$6.91 $6.45▼ −6.66%▼ −9.92%$6.89 (−0.29%)
Jul 10, 2026
15w ago
Insider Buy
BULLISH ★ 5/10
$6.22 $6.50▲ +4.50%▲ +0.51%$6.89 (+10.77%)
Jul 7, 2026
15w ago
Insider Buy
BULLISH ★ 5/10
$6.13 $6.32▲ +3.18%▲ +0.69%$6.89 (+12.49%)
Showing 10 of 16

US Market Status

Market Closed — Opens in 8h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 20, 2026